Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

This study makes a point with profound implications for when to treat cholesterol: it is not just how high your LDL is, but how long you have lived with it — and that early years count for more.

Tracking nearly 5,000 people, the investigators calculated each person’s cumulative LDL exposure — the “cholesterol-years” accumulated over the area under their LDL-versus-age curve. Higher cumulative exposure strongly predicted cardiovascular events, independent of current LDL level. Most striking, exposure between ages 18 and 30 was far more predictive than exposure between 30 and 40, and late lowering did not fully erase risk acquired early. The same cholesterol-years did more damage when accumulated young.

The clinical message is a quiet argument against waiting. Treating LDL only when it becomes “abnormal” in middle age forfeits the protection of preventing exposure in the first place. It reframes cholesterol as a lifetime burden best minimized early.

We rate the evidence strong. It is a sophisticated cohort analysis whose conclusion — that cumulative exposure and timing both matter — converges with the genetic Mendelian randomization data and reshapes thinking about the optimal moment to intervene.